MARKET

RGEN

RGEN

Repligen Corp
NASDAQ

Real-time Quotes | Nasdaq Last Sale

181.48
-4.71
-2.53%
After Hours: 181.48 0 0.00% 16:43 03/08 EST
OPEN
185.58
PREV CLOSE
186.19
HIGH
188.25
LOW
178.67
VOLUME
474.70K
TURNOVER
--
52 WEEK HIGH
228.84
52 WEEK LOW
78.41
MARKET CAP
9.94B
P/E (TTM)
163.73
1D
5D
1M
3M
1Y
5Y
Is Repligen Corporation (RGEN) A Smart Long-Term Buy?
Conestoga Capital Advisors, a boutique, independent investment management firm, published its fourth-quarter 2020 ‘Small Cap Growth & SMid Cap Growth’ Investor Letter – a copy of which can be downloaded here. A net return of 31% was recorded by Conestoga’s...
Insider Monkey · 16h ago
Cara Therapeutics' (CARA) Korsuva NDA Gets FDA Priority Review
Zacks.com · 17h ago
Downstream Processing market is expected to register a CAGR of above 13%. | ARC
pune, India, Mon, 08 Mar 2021 00:01:16 / Comserve Inc. / -- The global Downstream Processing market is expected to reach above US$ 42,754 Mn by 2026 and is...
Comserve · 1d ago
Global ELISA KitsMarket Research Report 2021 Market Insights, Overview, Analysis And Forecast 2021
Mar 06, 2021 (Heraldkeepers) -- The research report includes specific segments by region (country), by company, by Type and by Application. This study...
Heraldkeepers · 2d ago
Purification by Chromatography in Downstream Processing Market Size Report 2021 by Manufacturer Share, Price, Revenue, Gross Profit and Forecast to 2025
Mar 05, 2021 (The Expresswire) -- "Final Report will add the analysis of the impact of COVID-19 on this industry." “Purification by Chromatography in...
The Express Wire · 3d ago
Biotechnology Separation Systems Market 2021 Size Analysis by Manufactures, Types, Applications, Regions and Demand Forecast to 2024 Research Report by Absolute Reports
Mar 05, 2021 (The Expresswire) -- "Final Report will add the analysis of the impact of COVID-19 on this industry." The global market is further analyzed by...
The Express Wire · 3d ago
Global Perfusion Market CAGR Status 2021 Industry Size, Share, Growth Factor, Market Overview and Forecast to 2025
Mar 05, 2021 (The Expresswire) -- Global “Perfusion Market” research report provides up-to-date market information of Perfusion market which lets the reader...
The Express Wire · 4d ago
Solid-liquid Separation in Downstream Processing Market Classification, Opportunities, Types and Applications, Status and Forecast 2020 to 2027 By Ameco Research
pune, India, Fri, 05 Mar 2021 00:48:24 / Comserve Inc. / -- Solid-liquid Separation in Downstream Processing market to help players in achieving a strong...
Comserve · 4d ago
More
Forecast
Actual (USD)
Estimate (USD)
Income StatementMore
Net Income (USD)
YoY (%)
Balance SheetMore
Total Assets (USD)
Total Liabilities (USD)
Debt to Asset (%)
Cash FlowMore
Operating (USD)
YoY (%)
Learn about the latest financial forecast of RGEN. Analyze the recent business situations of Repligen Corp through EPS, BVPS, FPS, and other data. This information may help you make smarter investment decisions.
Analyst Rating

Based on 9 analysts

Buy

Disclaimer: The analysis information is for reference only and does not constitute an investment recommendation.

Analyst Price Target
The average RGEN stock price target is 228.57 with a high estimate of 251.00 and a low estimate of 168.00.
EPS
Institutional Holdings
Institutions: 611
Institutional Holdings: 51.62M
% Owned: 94.25%
Shares Outstanding: 54.77M
TypeInstitutionsShares
Increased
155
3.76M
New
129
47.80K
Decreased
150
2.75M
Sold Out
0
0
  • Performance
  • Asset Allocation
  • Dividend History
No Data
Industry
Medical Equipment, Supplies & Distribution
-0.72%
Healthcare Equipment & Supplies
-1.34%
Key Executives
Chairman/Independent Director
Karen Dawes
President/Chief Executive Officer/Director
Tony Hunt
President/Chief Executive Officer/Director
Anthony Hunt
Chief Financial Officer
Jon Snodgres
Senior Vice President
Ralf Kuriyel
Director
Carrie Eglinton
Independent Director
Nicolas Barthelemy
Independent Director
Rohin Mhatre
Independent Director
Glenn Muir
Independent Director
Thomas Ryan
No Data
About RGEN
Repligen Corporation is a bioprocessing company. The Company is focused on the development, manufacture and commercialization of products used to improve the interconnected phases of the biological drug manufacturing process. The Company's portfolio includes protein products, chromatography products, and filtration products. It provides Protein A ligands, a component of Protein A chromatography resins (media) used in the purification of virtually all monoclonal antibody (mAb)-based drugs on the market or in development. Its chromatography portfolio includes various products used in the downstream purification and quality control of biological drugs. Its OPUS pre-packed chromatography columns (PPCs) are used in the purification of clinical-stage biologics. Its filtration products include XCell Alternating Tangential Flow (ATF) Systems and Sius tangential flow filtration (TFF) cassettes. Sius TFF cassettes are used to concentrate clinical and commercial-stage biologic drugs.

Webull offers kinds of Repligen Corporation stock information, including NASDAQ:RGEN real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, RGEN stock news, and many more online research tools to help you make informed decisions.

You can practice and explore trading RGEN stock methods without spending real money on the virtual paper trading platform.